Skin Cancer News

• ASLMS 2022 PIH in Black Patients Responds to Laser Treatment: Case Series The case series included three patients with recalcitrant PIH and Fitzpatrick skin phototypes V and VI treated with a combination of topical and laser therapies.
  Medscape Medical News, May 04, 2022
• High Early Recurrence Rates With Merkel Cell Carcinoma The overall 5-year recurrence rate of this rare, aggressive skin cancer was 40% in a prospective cohort study.
  Medscape Medical News, March 03, 2022
• Confirmed: Cemiplimab Ups Survival in Recurrent Cervical Cancer Just published data from a phase 3 trial confirm that cemiplimab improves survival in patients with recurrent cervical cancer, as this indication awaits FDA approval.
  Medscape Medical News, February 09, 2022
• Sun-Protective Behaviors Differ Among Asian-American Subgroups Sun-protective behaviors differ among subgroups of Asian Americans and the differences may help identify those at high risk and inform culturally appropriate interventions, researchers say.
  Reuters Health Information, February 03, 2022
• First Guidelines for AI algorithms Used in Dermatology Released "We hope these guidelines also aid regulatory bodies around the world when they are assessing algorithms to be used in dermatology," one of the authors said.
  Medscape Medical News, December 22, 2021
• Sun-Protective Habits Not Linked With Poorer Bone Health The study goes a step further than previous research that has found sunscreen use does not compromise vitamin D synthesis and has little effect on circulating 25-hydroxyvitamin D levels.
  Medscape Medical News, October 29, 2021
• Benzene Testing Prompts Recalls of Spray Antifungals and Sunscreens The voluntary recall applies to several Lotrimin, Tinactin, and Coppertone spray sunscreen products.
  Medscape Medical News, October 08, 2021
• FDA Issues Proposed Order for Over-the-Counter Sunscreens "We see it as a key public health priority and our regulatory obligation to make sure that marketed sunscreen products offer protection from the sun's effects."
  Medscape Medical News, September 24, 2021
• Watchful Waiting in BCC: Which Patients Can Benefit? Some patients with basal cell carcinoma (BCC) may not need treatment. New data reveal who those patients likely are.
  Medscape Medical News, September 20, 2021
• Skin Cancer Prevention Guidance in Transplant Patients Published Despite a growing literature on prevention of CSCC in solid organ transplant recipients, uncertainty remains regarding best practices for various patient scenarios.
  Medscape Medical News, September 13, 2021
• TikTok Trends: Mr. Clean, DDS? We've braved the depths of TikTok for the trendiest health fads of the month and what physicians are saying about them. Buckle up for the internet's best, worst, and wildest words of advice.
  Medscape Medical News, September 09, 2021
• Med Students Lead Skin Cancer Screening, Education Event This disparity is reflected in statistics showing that the average 5-year survival rate for melanoma is 92% in White patients but drops down to 67% in Black patients.
  Medscape Medical News, August 31, 2021
• First-in-Class Gel Shows Promise for Basal-Cell Carcinoma A first-in-class topical histone deacetylation (HDAC) inhibitor has shown promise in the treatment of basal-cell carcinoma, the most common form of skin cancer.
  Reuters Health Information, August 13, 2021
• AK Treatments: Study Reviews Long-Term Efficacy Data The study reviewed data from 15 randomized clinical trials that reported sustained clearance rates after at least 12 months of treatment in adults with actinic keratosis.
  Medscape Medical News, August 12, 2021
• FDA Investigating Carcinogen Found in Recalled J&J Sunscreen Products The US Food and Drug Administration has said it is investigating the root cause of a cancer-causing chemical found in some of Johnson & Johnson's recalled sunscreen products.
  Reuters Health Information, July 16, 2021
• Stop Using Neutrogena and Aveeno Spray Sunscreen, J&J Warns The company has voluntarily issued a recall after finding low levels of benzene, a known cancer-causing agent, in some samples.
  WebMD Health News, July 15, 2021
• Metformin Use May Curb BCC Risk The decrease in basal cell carcinoma (BCC) risk was seen across all metformin dosing levels, but the reason for this remains unclear.
  Medscape Medical News, July 15, 2021
• EC Approves Cemiplimab for Advanced or Metastatic BCC The PD-1 inhibitor was approved by the Food and Drug Administration for this indication in the United States in February.
  Medscape Medical News, June 28, 2021
• Survey: Sun Protection Practices Fall Short of Intentions Four out of five adults know that sunscreen should be reapplied every 2 hours when they're outdoors, but only one in three make the effort.
  Medscape Medical News, June 21, 2021
• SID 2021 Topical HDAC Inhibitor Reduced BCC Size in Early Study Surgical excision is the preferred treatment for BCC, but there is still a need for noninvasive treatment options, the investigator pointed out.
  Medscape Medical News, June 14, 2021